Skip to main content

Advertisement

Log in

Increased serum osteopontin is a risk factor for osteoporosis in menopausal women

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

Osteopontin (OPN)-deficient mice are resistant to ovariectomy-induced osteoporosis. Therefore, we hypothesized that women with OPN overexpression may show less resistance to postmenopausal osteoporosis. In this study, we first demonstrated that serum OPN levels could be used as a biomarker for the early diagnosis of osteoporosis in postmenopausal women.

Introduction

Animal studies indicate that OPN-deficient mice are resistant to ovariectomy-induced osteoporosis.

Methods

From 2004 to 2006, 124 women over the age of 45 were enrolled in a menopausal group, while another 95 women, from 25 to 45 years of age with regular menstruation, were enrolled into a childbearing age group. The serum concentrations of OPN were calculated using the enzyme-link immunosorbent assay method, and bone mineral densities were determined with dual energy X-ray absorptiometry.

Results

Serum OPN levels had a significant positive correlation with age (menopausal group, p < 0.0001) and a negative correlation with body weight, height, hip bone mineral density, and T-scores in the menopausal group. In contrast, there was a positive correlation with the E2 concentration and height, but there was no significant association with the above variables in the childbearing age group. Additionally, high serum OPN levels (>14.7 ng/ml) was a significant risk factor causing menopausal osteoporosis (odds ratio = 2.96, 95% confidence interval, 1.055–8.345).

Conclusion

Serum OPN levels could be used as a biomarker for the early diagnosis of osteoporosis in postmenopausal women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Ishijima M, Ezura Y, Kunikazu T, Rittling SR, Kurosawa H, Denhardt DT, Emi M, Nifuji A, Noda M (2006) Osteopontin during tail-suspension-induced bone loss. Exp Cell Res 312:3075–3083

    Article  CAS  PubMed  Google Scholar 

  2. Rittling SR, Matsumoto HN, Mckee MD, Nanci A, An XR, Novick KE, Kowalski AJ, Noda M, Denhardt DT (1998) Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res 13:1101–1111

    Article  CAS  PubMed  Google Scholar 

  3. Rittling SR, Denhardt DT (1999) Osteopontin function in pathology: lessons from osteopontin-deficient mice. Exp Nephrol 7:103–113

    Article  CAS  PubMed  Google Scholar 

  4. Yoshitake H, Rittling SR, Denhardt DT, Noda M (1999) Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci U S A 96:8156–8160

    Article  CAS  PubMed  Google Scholar 

  5. Asou Y, Rittling SR, Yoshitake H, Tsuji K, Shinomiya K, Nifuji A, Denhardt DT, Noda M (2001) Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone. Endocrinology 142:1325–1332

    Article  CAS  PubMed  Google Scholar 

  6. Ihara H, Denhardt DT, Furuya K, Yamashita T, Muguruma Y, Tsuji K, Hruska KA, Higashio K, Enomoto S, Nifuji A, Rittling SR, Noda M (2001) Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin. J Biol Chem 276:13065–13071

    Article  CAS  PubMed  Google Scholar 

  7. Yumoto K, Ishijima M, Rittling SR, Tsuji K, Tsuchiya Y, Kon S, Nifuji A, Uede T, Denhardt DT, Noda M (2002) Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc Natl Acad Sci U S A 99:4556–4561

    Article  CAS  PubMed  Google Scholar 

  8. Morinobu M, Ishijima M, Rittling SR, Tsuji K, Yamamoto H, Nifuji A, Denhardt DT, Noda M (2003) Osteopontin expression in osteoblasts and osteocytes during bone formation under mechanical stress in the calvarial suture in vivo. J Bone Miner Res 18:1706–1715

    Article  CAS  PubMed  Google Scholar 

  9. Kitahara K, Ishijima M, Rittling SR, Tsuji K, Kurosawa H, Nifuji A, Denhardt DT, Noda M (2003) Osteopontin deficiency induces parathyroid hormone enhancement of cortical bone formation. Endocrinology 144:2132–2140

    Article  CAS  PubMed  Google Scholar 

  10. Chen Y, Bal BS, Gorski JP (1992) Calcium and collagen binding properties of osteopontin, bone sialoprotein, and bone acidic glycoprotein-75 from bone. J Biol Chem 267:24871–24878

    CAS  PubMed  Google Scholar 

  11. Hoyer JR, Otvos L Jr, Urge L (1995) Osteopontin in urinary stone formation. Ann N Y Acad Sci 760:257–265

    Article  CAS  PubMed  Google Scholar 

  12. MacNeli RL, Berry J, D'ErricoJ SC, Piotrowski B, Somerman MJ (1995) Role of two mineral-associated adhesion molecules, osteopontin and bone sialoprotein, during cementogenesis. Connect Tissue Res 33:1–7

    Article  Google Scholar 

  13. Horton MA, Nesbit MA, Helfrich MH (1995) Interaction of osteopontin with osteoclast integrins. Ann N Y Acad Sci 760:190–200

    Article  CAS  PubMed  Google Scholar 

  14. Giachelli CM, Liaw L, Murry CE, Schwartz S, Almeida MM (1995) Osteopontin expression in cardiovascular diseases. Ann N Y Acad Sci 760:109–126

    Article  CAS  PubMed  Google Scholar 

  15. Liaw L, Lombardi DM, Almeida MM, Schwartz SM, DeBlois D, Giachelli CM (1997) Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation. Arterioscler Thromb Vasc Biol 17:188–193

    CAS  PubMed  Google Scholar 

  16. Pichler R, Giachelli CM, Young B, Alpers CE, Couser WG, Johnson RJ (1995) The pathogenesis of tubulointerstitial disease associated with glomerulonephritis: the glomerular cytokine theory. Miner Electrolyte Metab 21:317–327

    CAS  PubMed  Google Scholar 

  17. Senger DR, Brown LF, Perruzzi CA, Papadopoulos-Sergiou A, Van de Water L (1995) Osteopontin at the tumor/host interface. Functional regulation by thrombin-cleavage and consequences for cell adhesion. Ann N Y Acad Sci 760:83–100

    Article  CAS  PubMed  Google Scholar 

  18. Weber GF, Ashkar S, Glimcher MJ, Cantor H (1996) Receptor–ligand interaction between CD44 and osteopontin (Eta-1). Science 271:509–512

    Article  CAS  PubMed  Google Scholar 

  19. Kennedy OD, Brennan O, Rackard SM, Staines A, O'Brien FJ, Taylor D, Lee TC (2009) Effects of ovariectomy on bone turnover, porosity, and biomechanical properties in ovine compact bone 12 months postsurgery. J Orthop Res 27:303–309

    Article  PubMed  Google Scholar 

  20. Shapses SA, Cifuentes M, Spevak L, Chowdhury H, Brittingham J, Boskey AL, Denhardt DT (2003) Osteopontin facilitates bone resorption, decreasing bone mineral crystallinity and content during calcium deficiency. Calcif Tissue Int 73(1):86–92

    Article  CAS  PubMed  Google Scholar 

  21. Ishijima M, Tsuji K, Rittling SR, Yamashita T, Kurosawa H, Denhardt DT, Nifuji A, Ezura Y, Noda M (2007) Osteopontin is required for mechanical stress-dependent signals to bone marrow cells. J Endocrinol 193(2):235–243

    Article  CAS  PubMed  Google Scholar 

  22. Kavukcuoglu NB, Denhardt DT, Guzelsu N, Mann AB (2007) Osteopontin deficiency and aging on nanomechanics of mouse bone. J Biomed Mater Res 83(1):136–144

    Article  Google Scholar 

  23. McCann RM, Colleary G, Geddis C, Clarke SA, Jordan GR, Dickson GR, Marsh D (2008) Effect of osteoporosis on bone mineral density and fracture repair in a rat femoral fracture model. J Orthop Res 26:384–393

    Article  PubMed  Google Scholar 

  24. Malaval L, Wade-Guéye NM, Boudiffa M, Fei J, Zirngibl R, Chen F, Laroche N, Roux JP, Burt-Pichat B, Duboeuf F, Boivin G, Jurdic P, Lafage-Proust MH, Amédée J, Vico L, Rossant J, Aubin JE (2008) Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis. J Exp Med 205(5):1145–1153

    Article  CAS  PubMed  Google Scholar 

  25. Denhardt DT, Noda M (1998) Osteopontin expression and function: role in bone remodeling. J Cell Biochem Suppl 31:92–102

    Article  Google Scholar 

  26. Choi ST, Kim JH, Kang EJ, Lee SW, Park MC, Park YB, Lee SK (2008) Osteopontin might be involved in bone remodeling rather than in inflammation in ankylosing spondylitis. Rheumatology 47:1775–1779

    Article  CAS  PubMed  Google Scholar 

  27. Le QT, Sutphin PD, Raychaudhuri S, Yu SC, Terris DJ, Lin HS, Lum B, Pinto HA, Koong AC, Giaccia AJ (2003) Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas. Clin Cancer Res 9(1):59–67

    CAS  PubMed  Google Scholar 

  28. Overgaard J, Eriksen JG, Nordsmark M, Alsner J, Horsman MR, Danish Head and Neck Cancer Study Group (2005) Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer. Lancet Oncol 6:757–764

    Article  CAS  PubMed  Google Scholar 

  29. Vordermark D, Said HM, Katzer A, Kuhnt T, Hansgen G, Dunst J, Flentije M, Bache M (2006) Plasma osteopontin lecels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system. BMC Cancer 207:1–6

    Google Scholar 

  30. Eastell R (2003) Pathogenesis of postmenopausal osteoporosis. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 5th edn. American Society for Bone and Mineral Research, Washington (DC), pp 314–316

    Google Scholar 

  31. Recker R, Lappe J, Davies K, Heaney R (2000) Characterization of perimenopausal bone loss: a prospective study. J Bone Miner Res 15:1965–1973

    Article  CAS  PubMed  Google Scholar 

  32. Abrahamsen B, Nissen N, Hermann AP, Hansen B, Bärenholdt O, Vestergaard P, Tofteng CL, Pors Nielsen S (2002) When should densitometry be repeated in healthy peri- and postmenopausal women? The Danish osteoporosis prevention study. J Bone Miner Res 17:2061–2067

    Article  CAS  PubMed  Google Scholar 

  33. Li Y, Li A, Yang X, Weitzmann MN (2007) Ovariectomy-induced bone loss occurs independently of B cells. J Cell Biochem 100(6):1370–1375

    Article  CAS  PubMed  Google Scholar 

  34. Suzuki K, Zhu B, Rittling SR, Denhardt DT, Goldberg HA, McCulloch CA, Sodek J (2002) Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts. J Bone Miner Res 17(8):1486–1497

    Article  CAS  PubMed  Google Scholar 

  35. Rajachar RM, Truong AQ, Giachelli CM (2008) The influence of surface mineral and osteopontin on the formation and function of murine bone marrow-derived osteoclasts. J Mater Sci Mater Med 19(10):3279–3285

    Article  CAS  PubMed  Google Scholar 

  36. Ono N, Nakashima K, Rittling SR, Schipani E, Hayata T, Soma K, Denhardt DT, Kronenberg HM, Ezura Y, Noda M (2008) Osteopontin negatively regulates parathyroid hormone receptor signaling in osteoblasts. J Biol Chem 283(28):19400–19409

    Article  CAS  PubMed  Google Scholar 

  37. Namkung-Matthai H, Appleyard R, Jansen J (2001) Osteoporosis influences the early period of fracture healing in a rat osteoporotic model. Bone 28:80–86

    Article  CAS  PubMed  Google Scholar 

  38. Roseleen M, McCann GC, Geddis C, Clarke SA, Jordan GR, Dickson GR, Marsh D (2008) Effect of osteoporosis on bone mineral density and fracture repair in a rat femoral fracture model. J Orthop Res 26:384–393

    Article  Google Scholar 

  39. D'Amore M, Fanelli M, D'Amore S, Fontana A, Minenna G (2006) Receptor activator of NF (Kappa) B ligand/osteoprotegerin (RANKL/OPG) system and osteoportnin (OPN) serum levels in a population of apullian postmenopausal women. Panminerva Med 48(4):215–221

    PubMed  Google Scholar 

  40. Vondracek SF, Hansen LB, McDermott MT (2009) Osteoporosis risk in premenopausal women. Pharmacotherapy 29(3):305–317

    Article  PubMed  Google Scholar 

  41. Bischoff L, Derk CT (2008) Premenopausal osteoporosis. Minerva Med 99(1):55–63

    CAS  PubMed  Google Scholar 

  42. Hamel ME, Sebaldt RJ, Siminoski K, Adachi JD, Papadimitropoulos AP, Goldsmith CH (2005) Influence of fracture history and bone mineral density testing on the treatment of osteoporosis in two non-academic community centers. Osteoporos Int 16:208–215

    Article  PubMed  Google Scholar 

  43. Solomon DH, Levin E, Helfgott SM (2000) Patterns of medication use before and after bone densitometry: factors associated with appropriate treatment. J Rheumatol 27:1496–1500

    CAS  PubMed  Google Scholar 

  44. Pressman A, Forsyth B, Ettinger B, Tosteson ANA (2001) Initiation of osteoporosis treatment after bone mineral density testing. Osteoporos Int 12:337–342

    Article  CAS  PubMed  Google Scholar 

  45. Hajcsar EE, Hawker G, Bogoch ER (2000) Investigation and treatment of osteoporosis in patients with fragility fractures. Can Med Assoc J 163:819–822

    CAS  Google Scholar 

  46. Ridout R, Hawker GA (2000) Use of bone densitometry by Ontario family physicians. Osteoporos Int 11:393–399

    Article  CAS  PubMed  Google Scholar 

  47. Papa LJ, Weber BE (1997) Physician characteristics associated with the use of bone densitometry. J Gen Intern Med 12:781–783

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from National Science Council (NSC97-2314-B-040-010-MY3) of Taiwan, People's Republic of China.

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Y.-W. Cheng.

Additional information

I.-C. Chang and T.-I. Chiang equally contributed to this study.

The authors have no proprietary or financial interest in any material or device mentioned.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chang, IC., Chiang, TI., Yeh, KT. et al. Increased serum osteopontin is a risk factor for osteoporosis in menopausal women. Osteoporos Int 21, 1401–1409 (2010). https://doi.org/10.1007/s00198-009-1107-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-009-1107-7

Keywords

Navigation